Home » Topics » Regulatory » Patents

Patents
RSS

Schering discloses new leukotriene antagonists particularly useful as dermatological products

Feb. 3, 1999

Improved salts of ACE inhibitors prepared at NicOx

Feb. 3, 1999

Tachykinin antagonists claimed by HMR for asthma, cough, bronchitis and pain

Feb. 3, 1999

New series of NHE inhibitors in development at Synthelabo

Feb. 3, 1999

GABA-A ligands useful for treating CNS disorders

Feb. 3, 1999

AMPA receptor antagonists in the pipeline at Schering

Feb. 2, 1999

Pharmacia & Upjohn describes new triazinic compounds with multiple pharmacological effects

Feb. 2, 1999

9a-Azalides with potent antibacterial activity in development at Merck

Feb. 2, 1999

New benzimidazoles useful in the treatment of diabetes and its complications under study at ADIR

Feb. 2, 1999

Bayer describes new oxazolidinone antibacterials in recently issued patent

Feb. 2, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...